updating data for batch codes

docs/SymptomsCausedByDrugs/data/ProportionalReportingRatios/vaccines/859.json

@@ -1 +1 @@
-{"acute generalised exanthematous pustulosis": 5.81, "acute kidney injury": 3.54, "agranulocytosis": 4.18, "asthma": 2.01, "atelectasis": 5.39, "blood alkaline phosphatase increased": 2.9, "blood magnesium decreased": 11.6, "blood pressure diastolic decreased": 24.3, "blood pressure systolic increased": 13.01, "body temperature decreased": 13.79, "bronchitis": 2.0, "cholestasis": 6.85, "chronic kidney disease": 5.9, "chronic obstructive pulmonary disease": 2.1, "completed suicide": 5.07, "crohn's disease": 2.34, "disease recurrence": 2.45, "drug interaction": 4.11, "drug reaction with eosinophilia and systemic symptoms": 8.98, "dyspepsia": 2.71, "dyspnoea exertional": 2.04, "ejection fraction decreased": 2.75, "end stage renal disease": 12.12, "eosinophilia": 7.55, "frequent bowel movements": 3.93, "full blood count abnormal": 4.52, "gamma-glutamyltransferase increased": 2.33, "gastritis": 2.32, "heart rate decreased": 4.13, "hepatic cytolysis": 6.66, "hepatic enzyme increased": 2.0, "hepatitis cholestatic": 7.33, "hip fracture": 2.88, "hypocalcaemia": 15.47, "hypokalaemia": 2.56, "hypomagnesaemia": 42.14, "hyponatraemia": 7.96, "inappropriate antidiuretic hormone secretion": 6.64, "large intestine polyp": 8.07, "loss of personal independence in daily activities": 2.45, "nephropathy": 4.87, "obstructive airways disorder": 5.83, "premature labour": 8.15, "productive cough": 2.79, "pseudomembranous colitis": 14.71, "rash maculo-papular": 8.01, "rebound acid hypersecretion": 380.76, "renal failure": 2.08, "renal injury": 3.01, "sleep disorder due to a general medical condition": 13.13, "suspected suicide": 14.87, "therapeutic product effect incomplete": 2.09, "thrombocytopenia": 2.24, "toxic epidermal necrolysis": 7.39, "toxic skin eruption": 4.44, "tubulointerstitial nephritis": 14.32, "vitamin b12 deficiency": 16.99, "wheezing": 4.06}
+{"alanine aminotransferase increased": 7.72, "alveolar soft part sarcoma": 2533.51, "amylase increased": 6.4, "ascites": 2.36, "aspartate aminotransferase increased": 6.57, "blood alkaline phosphatase increased": 2.4, "blood bilirubin increased": 10.17, "blood pressure increased": 2.36, "blood thyroid stimulating hormone increased": 11.62, "cardiac failure": 2.18, "clear cell renal cell carcinoma": 479.39, "decreased appetite": 3.34, "diarrhoea": 2.86, "disease progression": 3.48, "drug intolerance": 3.43, "drug-induced liver injury": 10.1, "haemoptysis": 3.16, "hair colour changes": 87.21, "hepatic enzyme increased": 2.67, "hepatic failure": 3.84, "hepatic function abnormal": 9.18, "hepatotoxicity": 25.15, "hyperbilirubinaemia": 11.93, "hypertension": 5.88, "hypertransaminasaemia": 7.1, "hypothyroidism": 8.1, "intestinal perforation": 9.57, "jaundice": 5.1, "liver function test abnormal": 3.37, "liver function test increased": 5.4, "liver injury": 6.17, "malignant neoplasm progression": 30.17, "metastases to bone": 12.42, "metastases to central nervous system": 14.17, "metastases to liver": 11.04, "metastases to lung": 51.22, "metastases to lymph nodes": 17.74, "metastatic renal cell carcinoma": 61.89, "mucosal inflammation": 3.35, "nephrotic syndrome": 5.46, "neutropenia": 2.28, "osteosarcoma metastatic": 1076.44, "palmar-plantar erythrodysaesthesia syndrome": 16.47, "platelet count decreased": 2.95, "pleural effusion": 3.61, "pneumothorax": 39.06, "posterior reversible encephalopathy syndrome": 14.02, "product use in unapproved indication": 12.95, "proteinuria": 9.11, "pulmonary mass": 5.38, "renal cancer": 10.63, "renal cell carcinoma": 31.3, "soft tissue sarcoma": 406.77, "stomatitis": 2.02, "therapeutic response decreased": 6.9, "therapy partial responder": 12.32, "thrombocytopenia": 2.96, "toxicity to various agents": 2.8, "transaminases increased": 11.0}